Botanical species · safety record

Trichosanthes kirilowii

The EFSA Compendium of Botanicals holds 4 constituent measurements for Trichosanthes kirilowii. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Trichosanthes kirilowii Maxim.

4Constituent measurements
0Safety records
4Cited sources
428Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 428 licensed products naming Trichosanthes kirilowii as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Fresh
  • solid

Source material stated

  • Dried pericarp of the ripe fruit
  • Dried root(s)
  • Fructus
  • Fruit
  • Fruit peel
  • Fruit pericarp
  • Fruit(s)
  • New material

What the records describe

Constituents measured

  • Cucurbitacin b2
  • Lignans1
  • Trichosanthin1

Plant parts

  • Roots and other underground parts1
  • Roots and other underground parts used as staple food1
  • Seed1
  • Unspecified1

Preparations

  • Solvent extraction3

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Cucurbitacin bUnspecifiedSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Cucurbitacin bRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
LignansSeedUnspecifiedResolve DOI
TrichosanthinRoots and other underground parts used as staple foodSolvent extractionChromatographic testsResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Ding, Xiuli., Chi, Jiadong., Yang, Xue., Hao, Jian., Liu, Chang., Zhu, Cuihong., Wang, Xiaodong., Liu, Xiaohui., Niu, Yangyang., Ji, Wei., Chen, Dan., Wu, Xiongzhi. Cucurbitacin B synergistically enhances the apoptosis-inducing effect of arsenic trioxide by inhibiting STAT3 phosphorylation in lymphoma Ramos cells . Leukemia & lymphoma, 2017, vol. 58, no. 10, p. 2439-2451. DOI
  2. Ryu, Shi Yong., Lee, Seung Ho., Choi, San Un., Lee, Chong Ock., No, Zaesung., Ahn, Jong Woong. Antitumor activity of Trichosanthes kirilowii. Archives of pharmacal research (seoul), 1994, vol. 17, no. 5, p. 348-353. DOI
  3. Lee, Eunyoung., Ahamed, V. S. Jamal., Kumar, Mahto Sanjeev., Rhee, Seog Woo., Moon, Surk-Sik., Hong, In Seok. Synthesis and evaluation of cytotoxic effects of hanultarin and its derivatives . Bioorganic & medicinal chemistry letters, 2011, vol. 21, no. 21, p. 6245-6248. DOI
  4. CHAN, WY., NG, TB., WU, PJ., YEUNG, HW. DEVELOPMENTAL TOXICITY AND TERATOGENICITY OF TRICHOSANTHIN, A RIBOSOME-INACTIVATING PROTEIN, IN MICE . Teratogenesis carcinogenesis and mutagenesis, 1993, vol. 13, no. 2, p. 47-57. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue